In a mouse model for hepatocellular carcinoma, ectopic expression of IL-33 in tumor cells or hydrodynamical injection of IL-33–expressing plasmids into the liver of tumor-bearing mice inhibited tumor development by promoting effector CD4+ and CD8+ T cell activation and IFN-γ production [166]. Here, IL33 is linked to hepatocellular carcinoma.